Following the IP bread crumb trial along with James latest interview, he mentions at the 3:00 minute mark the idea of combination therapies and the need to talk with those other drug companies. Looks and now sound likes they are widening their scoop of works for this drug. Great job and great to hear so many positive voices on this thread for a change.
- Forums
- ASX - By Stock
- Cantrixil Study
Following the IP bread crumb trial along with James latest...
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online